â??Translation and Testing of the PeNAT tool for measuring Nausea in the Hindi-speaking Indian populatio
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2020/10/028271
- Lead Sponsor
- Prof Sameer Bakhshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Age between 4 years to <=18 years, and willing to participate in the study.
2. Patients with a history of pathologically confirmed malignancies.
3. Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2.
4. Both the child and their guardian understand Hindi.
5. For inclusion in group 1, pretesting, or pilot testing: Pediatric cancer patients currently undergoing highly-emetogenic or moderately emetogenic chemotherapy.
6. For inclusion in group 2, pretesting, or pilot testing: Pediatric cancer patients currently on treatment, but not having received chemotherapy within the past five days.
7. For inclusion in group 3: Cancer survivors, currently not on any form of therapy.
1. Any physical or cognitive impairments that preclude the use of PeNAT, such as blindness or mental retardation.
2. Any history of CNS disease including brain metastasis, seizure disorder, developmental disorder, or psychosis
3. For patients in group 2, any patient having gastrointestinal ailments such as neutropenic colitis at the time of testing will be excluded.
4. Not willing to participate in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method